A complex pheotype in a girl with a novel heterozygous missense variant (p.Ile56Phe) of the GNAS gene
Open Access
- 23 February 2022
- journal article
- research article
- Published by Springer Nature in Orphanet Journal of Rare Diseases
- Vol. 17 (1) , 1-12
Abstract
Background: GNAS is a complex gene that encodes Gsα, a signaling protein that triggers a complex network of pathways. Heterozygous inactivating mutations in Gsα-coding GNAS exons cause hormonal resistance; on the contrary, activating mutations in Gsα result in constitutive cAMP stimulation. Recent research has described a clinical condition characterized by both gain and loss of Gsα function, due to a heterozygous de novo variant of the maternal GNAS allele. Patients and methods: We describe a girl with a complex combination of clinical signs and a new heterozygous GNAS variant. For the molecular analysis of GNAS gene, DNA samples of the proband and her parents were extracted from their peripheral blood samples. In silico analysis was performed to predict the possible in vivo effect of the detected novel genetic variant. The activity of Gsα protein was in vitro analyzed from samples of erythrocyte membranes, recovered from heparinized blood samples. Results: We found a new heterozygous missense c.166A > T—(p.Ile56Phe) GNAS variant in exon 2, inherited from the mother that determined a reduced activity of 50% of Gsα protein function. The analysis of her parents showed a 20–25% reduction in Gsα protein activity in the mother and a normal function in the father. Clinically our patient presented a multisystemic disorder characterized by hyponatremia compatible with a nephrogenic syndrome of inappropriate antidiuresis, subclinical hyperthyroidism, subclinical hypercortisolism, precocious thelarche and pubarche and congenital bone abnormalities. Conclusions: This is the first time that the new variant c.166A > T (p.Ile56Phe) on exon 2 of GNAS gene, originated on maternal allele, has been described as probable cause of a multisystemic disorder. Although the mutation is associated with a reduced activity of the function of Gsα protein, this unusual phenotype on the contrary suggests a mild functional gain.Keywords
This publication has 30 references indexed in Scilit:
- McCune-Albright syndrome and the extraskeletal manifestations of fibrous dysplasiaOrphanet Journal of Rare Diseases, 2012
- A novel aspect of GNAS imprinting: Higher maternal expression of Gαs in human lymphoblasts, peripheral blood mononuclear cells, mammary adipose tissue, and heartMolecular and Cellular Endocrinology, 2011
- Gsα activity is reduced in erythrocyte membranes of patients with psedohypoparathyroidism due to epigenetic alterations at the GNAS locusJournal of Bone and Mineral Research, 2011
- Central Nervous System Imprinting of the G Protein Gsα and Its Role in Metabolic RegulationCell Metabolism, 2009
- Clinical and hematologic features of 300 patients affected by hereditary spherocytosis grouped according to the type of the membrane protein defectHaematologica, 2008
- Studies of the regulation and function of the Gsα gene Gnas using gene targeting technologyPharmacology & Therapeutics, 2007
- Assembly and Trafficking of Heterotrimeric G ProteinsBiochemistry, 2007
- Inherited Diseases Involving G Proteins and G Protein–Coupled ReceptorsAnnual Review of Medicine, 2004
- Pseudohypoparathyroidism2002
- Rapid GDP release from Gsα in patients with gain and loss of endocrine functionNature, 1994